Sanatorio Allende Cerro

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis2 trials
• Bladder cancer1 trial
• Endometrial cancer1 trial
• Lung cancer1 trial

Phase

• Phase 35 trials

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Enrolling by invitation1 trial

Lead sponsor

• United Therapeutics2 trials
• Daiichi Sankyo1 trial
• Janssen Research & Development, LLC1 trial
• Seagen, a wholly owned subsidiary of Pfizer1 trial

Running trials

• Recruiting

  A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting

  NCT07022483· Phase 3· Daiichi Sankyo· Source

• Active, not recruiting

  A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

  NCT06012435· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source

• Recruiting

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· Phase 3· United Therapeutics· Source

  Contact: Maria Gracia de la Vega

• Enrolling by invitation

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· Phase 3· United Therapeutics· Source

• Active, not recruiting

  A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

  NCT04658862· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Idiopathic pulmonary fibrosis2 recruiting
• Endometrial cancer1 recruiting